Transcript below:
Hi everyone, I'm Rick Rowan. I'm a healthcare entrepreneur and in this episode I want to address a few misconceptions about bioelectronic technology.
You have to think about bioelectronics as the electronic version of pharmaceuticals, which is why the industry is also referred to as electroceuticals.
Now, the pharmaceutical industry, among many other industries, is often accused of selective science in relation to both its claims of safety or side effect profiles as well as efficacy or claims. At the very least these accusations of selective practice are relative to claims about the actual compound or drug in question. For example, fentanyl claims are about fentanyl or statins are about statins etc.
What I want you to be aware of is that in the world of electrotherapy devices, the issue can be more complex. The difference is that claims are often not related to what an actual device is delivering, but taken literally from any electrotherapy study that fits its marketing agenda or product claims. Could you imagine Paracetamol manufacturers using the studies of Morphine or Ibuprofen, simply because they're also a pill? This is too often what is happening in electroceuticals, due to lack of knowledge and education.
This lack of understanding is hindering uptake and advancement, which could help millions of patients globally that could be receiving the life-changing or even life-saving benefits of electroceuticals.
